Abstract:Hepatocellular carcinomas (HCCs) are tumors with a highly developed vascular architecture. HCC cells require access to blood vessels for growth and metastasis; therefore, the inhibition of angiogenesis represents a potential therapeutic target for HCC that may reduce the mortality and morbidity from HCC. Various attempts to develop an anti-angiogenic therapy have been made in past decades; however, modest results have been achieved in clinical trials and the challenge of HCC treatment remains. Single-chain antibodies (scFv) are characterized by low molecular weight, low immunogenicity, high penetration and a short half-life, and are easy to produce on a large scale by genetic engineering. Accordingly, an scFv against a specific angiogenic regulator, such as angiopoietin (Ang), may be a promising anti-angiogenic therapy for HCC. Our previous study indicated that an imbalanced expression of angiopoietin-2 (Ang-2) vs. angiopoietin-1 (Ang-1) in HCCs contributes to initiation of neovascularization and promotes the angiogenesis and progression of HCCs. Therefore, we suggest that specific Ang-2-targeting interventions may be valuable in the treatment of HCC via remodeling the neovascular network and changing the tumor microenvironment. In this study, a prokaryotic expression vector of Ang-2 was constructed and purified human Ang-2 protein was isolated. An scFv against human Ang-2 (scFv-Ang2) was identified and purified via phage display technology, and the effects of scFv-Ang2 in vitro and in vivo on HCC in nude mice were evaluated. The results show that scFv-Ang2 inhibits vascular endothelial growth factor (VEGF) and Ang-2 induces the proliferation, migration and tubule formation of human umbilical vein endothelial cells (HUVECs) in vitro. In the in vivo assay, statistical indices, including tumor weight and volume, metastases to lungs, CD31 expression and the microvessel density (MVD) count in the scFv-Ang2-treated group of mice were significantly lower than those in the control group (P<0.05). In conclusion, the successfully generated scFv-Ang2 showed significant inhibitory effects on the angiogenesis and tumor growth of human HCC in vitro and in vivo.

[Recombinant Adenovirus Vectors Carrying Antisense Matrix Metalloproteinase-2 Inhibits Hepatocellular Carcinoma Growth in Vivo].

Inhibition of Adenovirus-Mediated Gene Transfer of Antisense Matrix Metalloproteinase-2 on Hepatocellular Carcinoma Growth in Vivo

[Recombinant Adenovirus Vectors Carrying Antisense MMP2 Inhibit Invasion of HCC Cells in Vitro].

Inhibitory Effect of Antisense Matrix Metalloproteinase-2 Mediated by Adenovirus on Hepatocellular Carcinoma Growth and Angiogenesis in Vivo

Construction of LASS2 gene recombinant adenovirus and its effect on the inhibition of metastasis of hepatocellular carcinoma cell line HCCLM3

Bc047440 Antisense Eukaryotic Expression Vectors Inhibited Hepg(2) Cell Proliferation and Suppressed Xenograft Tumorigenicity

Adenovirus-mediated Tissue-Specific Cytosine Deaminase Gene Therapy for Human Hepatocellular Carcinoma with Different AFP Expression Levels.

[Adenovirus-Mediated Antisense HSP70 Cdna Transfection Inhibits the Growth of Laryngeal Carcinoma Hep-2 Cells].

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

[Tumor-Targeting Expression of a New Tumor Suppressor Gene HCCS1 and Its Tumor-Selective Inhibitory Effects on Hepatocellular Carcinoma].

A novel recombinant adenovirus expressing apoptin and melittin genes kills hepatocellular carcinoma cells and inhibits the growth of ectopic tumor

Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma

Specific Inhibition of Hepatocarcinoma Cells by Recombinant Adenovirus Expressing Melittin

[Inhibitive Effects of Recombinant Adenovirus-Mediated Human Endostatin on the Growth of Human Hepatocellular Carcinoma Xenograft in Nude Mice].

Inhibitory Effect of Adeno-Associated Virus-Mediated Gene Transfer of Human Endostatin on Hepatocellular Carcinoma

Adenovirus Mediated Overexpression of Mir-99A Inhibits the Growth of Hepatocellular Carcinoma Cells

Antiangiogenesis Gene Armed Tumor‐targeting Adenovirus Yields Multiple Antitumor Activities in Human HCC Xenografts in Nude Mice

Hepatic Arterial Injection of Recombinant Adenovirus Microspheres Carrying Antisense Multidrug Resistance-Associated Protein Gene for Hepatocellular Cancer in Rats

Inhibitory Effect of Antisense Vascular Endothelial Growth Factor 165 Eukaryotic Expression Vector on Proliferation of Hepatocellular Carcinoma Cells

Suppression Of Angiogenesis And Tumor Growth In Vitro And In Vivo Using An Anti-Angiopoietin-2 Single-Chain Antibody

Effect of Recombinant Adenovirus Harboring Melittin Gene on Growth of HepG2 Cells and AFP Expression